MoneyWorks4Me

Sanjivani Paranteral informs about scrutinizers report

24 Aug 2026 Evaluate
Further to letter dated 23rd July, 2026, Sanjivani Paranteral has informed that pursuant to Section 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, the members of the Company have duly approved, through remote e-voting facility the special business as specified in the Postal Ballot Notice dated 23rd July, 2026. The details of the voting results in the format prescribed under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Scrutinizer’s Report is enclosed. 

The above information is a part of company’s filings submitted to BSE.

Sanjivani Paranteral Share Price

193.00 -1.35 (-0.69%)
03-Sep-2026 14:13 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1916.45
Dr. Reddys Labs. 1157.80
Cipla 1396.20
Lupin 2146.00
Zydus Lifesciences 1138.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: